Cannabinoid Receptor Type 1 Expression in the Developing Avian Retina: Morphological and Functional Correlation With...

Area of Science:

• Neuroscience
• Developmental Biology
• Retinal Research

Background:

• The avian retina serves as a model for neuro- and gliotransmitter signaling.
• The interplay between dopaminergic and cannabinoid systems in the retina is not well understood.

Purpose of the Study:

• To investigate the expression and localization of cannabinoid receptors (CB1, CB2) and MAGL during avian retina development.
• To explore the relationship between the endocannabinoid and dopaminergic systems in the developing avian retina.

Main Methods:

• Immunohistochemistry to detect CB1, CB2, and MAGL expression in retinal tissues at different developmental stages (E5-PE7).
• Cellular localization studies using co-expression analysis with specific markers (TH, D1 receptor).
• Primary cell culture experiments to assess the functional interaction between CB1 and D1 receptors on cAMP signaling.

Main Results:

• CB1 receptor expression is high from embryonic day 5 (E5) to post-hatched day 7 (PE7), decreasing with development, primarily in the ganglion cell layer (GCL) and inner plexiform layer (IPL).
• CB2 receptor expression is also present from E5 to PE7, with reduced levels after E9, mainly in the IPL. MAGL is expressed across retinal layers, particularly in the IPL and outer plexiform layer (OPL), in Müller glia.
• CB1 co-localizes with tyrosine hydroxylase (TH) and D1 receptors in mature retinas, and activation of CB1 inhibits D1-mediated cAMP accumulation.

Conclusions:

• The endocannabinoid and dopaminergic systems are correlated during avian retina development.
• CB1 receptor activation modulates D1 receptor signaling, potentially influencing retinal differentiation and embryological parameters.